- Filed
- Mar 16, 2016 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2016 · Mar 10, 2016 | 17.26M sh |
| Long Term Debt | Q2 2016 · Jan 31, 2016 | $7.9M |
| Long Term Debt | Q2 2016 · Jul 31, 2015 | $9.08M |
| Stockholders Equity | Q2 2016 · Jan 31, 2016 | $28.22M |
| Stockholders Equity | Q2 2016 · Jul 31, 2015 | $26.95M |
| Current Liabilities | Q2 2016 · Jan 31, 2016 | $12.13M |
| Current Liabilities | Q2 2016 · Jul 31, 2015 | $12.94M |
| Total Liabilities | Q2 2016 · Jan 31, 2016 | $20.52M |
| Total Liabilities | Q2 2016 · Jul 31, 2015 | $22.69M |
| Current Assets | Q2 2016 · Jan 31, 2016 | $9.35M |
| Current Assets | Q2 2016 · Jul 31, 2015 | $8.41M |
| Total Assets | Q2 2016 · Jan 31, 2016 | $48.75M |
| Total Assets | Q2 2016 · Jul 31, 2015 | $49.64M |
| Net Income | Q2 2016 · Jan 31, 2016 | $448K |
| Net Income | Q2 2016 · Jan 31, 2016 | $837K |
| Net Income | Q2 2016 · Jan 31, 2015 | $260K |
| Net Income | Q2 2016 · Jan 31, 2015 | $364K |
| Shares Diluted restated | Q2 2016 · Jan 31, 2015 | 14.86K sh |
| Shares Diluted restated | Q2 2016 · Jan 31, 2015 | 14.48K sh |
| Capex | Q2 2016 · Jan 31, 2015 | $279K |
| Cash And Equivalents | Q2 2016 · Jan 31, 2015 | $1.69M |
| Cash And Equivalents | Q2 2016 · Jul 31, 2014 | $1.81M |
| Eps Diluted | Q2 2016 · Jan 31, 2015 | $0.02 |
| Eps Diluted | Q2 2016 · Jan 31, 2015 | $0.03 |
| Eps Basic | Q2 2016 · Jan 31, 2015 | $0.02 |
| Eps Basic | Q2 2016 · Jan 31, 2015 | $0.03 |
| Sga Expense | Q2 2016 · Jan 31, 2015 | $1.59M |
| Sga Expense | Q2 2016 · Jan 31, 2015 | $3.19M |
| Operating Income | Q2 2016 · Jan 31, 2015 | $670K |
| Operating Income | Q2 2016 · Jan 31, 2015 | $953K |
| Gross Profit | Q2 2016 · Jan 31, 2015 | $8.28M |
| Gross Profit | Q2 2016 · Jan 31, 2015 | $15.64M |